New quinoxalin‐1,3,4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies-Reference-Cited by-同舟云学术

New quinoxalin‐1,3,4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies

Published:2021-05-17 Issue:9 Volume:354 Page:2000471
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch Pharm

Author:

Mirzazadeh Roghieh¹,Asgari Mohammad S.²,Barzegari Ebrahim³,Pedrood Keyvan⁴,Mohammadi‐Khanaposhtani Maryam⁵,Sherafati Maedeh⁴,Larijani Bagher⁴,Rastegar Hossein⁶,Rahmani Hojjat⁷,Mahdavi Mohammad⁴,Taslimi Parham⁸^ORCID,Üç Eda M.⁹,Gulçin İlhami⁹

Affiliation:

1. Department of Biochemistry Pasteur Institute of Iran Tehran Iran

2. Department of Chemistry Iran University of Science and Technology Tehran Iran

3. Medical Biology Research Center, Health Technology Institute Kermanshah University of Medical Sciences Kermanshah Iran

4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences Tehran Iran

5. Cellular and Molecular Biology Research Center, Health Research Institute Babol University of Medical Sciences Babol Iran

6. Cosmetic Products Research Center Iranian Food and Drug Administration, MOHE Tehran Iran

7. Department of Health Management and Economics, School of Public Health Tehran University of Medical Sciences Tehran Iran

8. Department of Biotechnology, Faculty of Science Bartin University Bartin Turkey

9. Department of Chemistry, Faculty of Science Ataturk University Erzurum Turkey

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.202000471

Reference68 articles.

1. 1,3,4-Oxadiazole: A Biologically Active Scaffold

2. Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes

3. Novel Molecular Hybrids of N-Benzylpiperidine and 1,3,4-Oxadiazole as Multitargeted Therapeutics to Treat Alzheimer’s Disease

4. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer’s disease

5. Synthesis, characterization and biological evaluation of novel 2,5 substituted-1,3,4 oxadiazole derivatives

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of cholinesterase and α-glucosidase enzyme activities, and molecular docking and dft studies for 1,2-disubstituted cyclopentane derivatives with phenyl and benzyl units;Molecular Diversity;2024-07-08

2. Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review;Archiv der Pharmazie;2024-04-29

3. Investigation of cholinesterase and α-glucosidase enzyme activities, and molecular docking and dft studies for 1,2-disubstituted cyclopentane derivatives with phenyl and benzyl units;2024-02-08

4. Screening of Inhibitory Effects Lanosterol on Butyrylcholinesterase, Acetylcholinesterase and Carbonic Anhydrase Enzymes;Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi;2023-12-01

5. In silico identification of novel heterocyclic compounds combats Alzheimer’s disease through inhibition of butyrylcholinesterase enzymatic activity;Journal of Biomolecular Structure and Dynamics;2023-09-18